Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05155696
Other study ID # SMU_ETHICS_2020-21_240
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 6, 2022
Est. completion date September 26, 2023

Study information

Verified date September 2023
Source St. Mary's University, Twickenham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomised, placebo controlled trial explores the effects of supplementation with a probiotic drink (kefir) in children diagnosed with ADHD on behaviour, sleep, attention and the gut microbiome.


Description:

Children with Attention Deficit Hyperactivity Disorder (ADHD) can suffer debilitating symptoms, including problematic behaviour and sleep. Dietary manipulations may be a helpful treatment option for children, but the most effective are highly restrictive, with little known about why they might work. Optimising gut bacteria may help alleviate some of the symptoms of this condition via the gut-brain-axis. The consumption of a probiotic fermented drink (kefir) can positively influence composition of gut bacteria. The purpose of this study is to explore the effects of supplementation of a probiotic drink (kefir) on behaviour, sleep, attention and the gut microbiome in children diagnosed with ADHD. In a six-week randomised controlled double-blind, placebo controlled trial, 70 children diagnosed with ADHD (aged 8-13 years) will be randomised to be given either a probiotic drink (kefir) or a placebo drink. At the beginning and the end of the study a combination of questionnaires, cognitive assessment, sleep/physical activity measures and microbiome analysis will be employed to assess the effect of kefir consumption on symptoms of ADHD and the gut microbiome.


Recruitment information / eligibility

Status Completed
Enrollment 81
Est. completion date September 26, 2023
Est. primary completion date September 26, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 13 Years
Eligibility Inclusion Criteria: - A previous diagnosis of ADHD according to the DSM-IV or DSM-V criteria by a qualified health care professional. - Children aged between 8 and 13 years at the time of study. - Children with a comorbidity will be accepted. - Both males and females Exclusion Criteria: - Children currently undergoing a current course of behavioural therapy. - Children with a reported milk allergy or lactose intolerance. - Reported use of antibiotics, probiotics, antifungals or steroids in the past four weeks. - Diagnosis of a gastrointestinal disorder e.g., Inflammatory Bowel Disease or Coeliac disease. - Diagnosis of an auto-immune disease or compromised immunity.

Study Design


Related Conditions & MeSH terms

  • ADHD
  • Attention Deficit Disorder with Hyperactivity

Intervention

Dietary Supplement:
Experimental: Kefir probiotic drink (supplied by Nourish)
125ml per day of dairy based probiotic drink (Kefir) containing = 50billion colony forming units (CFU), supplied in plain packaging.
Placebo comparator
125ml of non-fermented dairy based placebo (UHT milk) per day, supplied in plain packaging.

Locations

Country Name City State
United Kingdom St Mary's University London Greater London

Sponsors (3)

Lead Sponsor Collaborator
St. Mary's University, Twickenham Goldsmiths, University of London, London South Bank University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in The Strengths and Weakness of ADHD-symptoms and Normal-behaviour (SWAN) scale 18 item scale comparing the child to other children of the same age. Each item is responded to on a seven-point scale ranging from far below average (-3) to far above average (+3).
The scores are summed and divided by the number of items, to express the summary score as the average rating-per-item (range -3 to +3, with lower scores indicating more severe ADHD symptoms).
week 0 and week 6
Secondary Change in The Go/NoGo test Participants respond to a particular stimulus while various stimuli are presented on a computer screen. There are 1500 milliseconds between each response, with 320 repetitions.
Go errors (errors of omission) - A higher score = greater inattention (worse)
NoGo errors (errors of commission) - A higher score = greater impulsivity (worse)
Go reaction times - A higher score = less impulsivity (better)
Go reaction time variability - A higher score = greater inattention (worse)
week 0 and week 6
Secondary Change in mean activity during sleep. Actigraphy recordings. Range 0-8. A higher score = less sound sleep (worse). week 0 and week 6
Secondary Change in minutes spent awake during the down period Actigraphy recordings. Range 0-8. A higher score = less sound sleep (worse). week 0 and week 6
Secondary Change in sleep latency Actigraphy recordings of time taken to fall asleep. Range 0-8. A higher score = more time taken to fall asleep (worse). week 0 and week 6
Secondary Change in sleep efficiency Actigraphy recordings of % down period spent asleep, after removing sleep latency. A higher score = better. week 0 and week 6
Secondary Change in wake after sleep onset Actigraphy recordings of minutes spent awake during the down period after removing sleep latency. Range 0-8. A higher score = less sound sleep (worse). week 0 and week 6
Secondary Change in sleep fragmentation Actigraphy recordings of the number of awakenings/ total minutes of sleep x 100) - Higher score = more fragmented sleep (worse). week 0 and week 6
Secondary Change in mean daytime activity Actigraphy recording of mean daytime activity. (0-8) not necessarily worse or better. week 0 and week 6
Secondary The Consensus Sleep diary Record of sleep - used qualitatively to detect and remove artefacts from the data. Takes approximately 3 minutes per day to complete. week 0 and week 6
Secondary The Consensus Sleep diary Record of sleep - used qualitatively to detect and remove artefacts from the data. Takes approximately 3 minutes per day to complete. week 6
Secondary Change in The Child's Sleep habits questionnaire Consists of 33 items. Each item is rated by parents using a three-point scale (with some items reverse-scored):
3 - Usually =occurs 5+ times a week 2 - Sometimes = occurs 2-4 times a week
1 - Rarely = occurs 0-1 times a week
A Total Sleep Disturbances score is calculated as the sum of all scored questions.
Total scores range from 33 to 99 - higher scores indicate more problematic sleep.
week 0 and week 6
Secondary Change in Sleep self report Consists of 26 items. Each item is rated by children using a three-point scale (with some items reverse-scored):
3 - Usually = occurs 5+ times a week 2 - Sometimes = occurs 2-4 times a week
1 - Rarely = occurs 0-1 times a week.
A Total Sleep Disturbances score is calculated as the sum of all scored questions.
Total scores range from 26 to 78 - higher scores indicate more problematic sleep.
week 0 and week 6
Secondary Change in The Gastrointestinal Severity Index A three-point rating scale across six gastrointestinal symptoms. A higher scores indicate worse symptoms.
Total scores range from 0-12 - higher scores indicating more severe symptoms.
week 0 and week 6
Secondary Change in stool microbiome analysis Investigate if there are changes in diversity and species in week 6 relative to week 0. week 0 and week 6
See also
  Status Clinical Trial Phase
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Recruiting NCT06038942 - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress N/A
Not yet recruiting NCT06456372 - Digital Health Intervention for Children With ADHD N/A
Completed NCT05518435 - Managing Young People With ADHD in Primary Care Study
Active, not recruiting NCT04978792 - Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD? N/A
Completed NCT03216512 - Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD N/A
Not yet recruiting NCT02906501 - Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances N/A
Completed NCT02829528 - Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention N/A
Completed NCT02900144 - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT) N/A
Completed NCT02562469 - ACTIVATE: A Computerized Training Program for Children With ADHD N/A
Terminated NCT02271880 - Improving Medication Adherence in ADHD Adolescents N/A
Recruiting NCT02255565 - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Phase 4
Completed NCT02463396 - Mindfulness Training in Adults With ADHD N/A
Completed NCT01673594 - Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist Phase 4
Terminated NCT01733680 - Amiloride Hydrochloride as an Effective Treatment for ADHD Early Phase 1
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Active, not recruiting NCT01137318 - Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT01404273 - Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder N/A
Completed NCT00573859 - The Reinforcing Mechanisms of Smoking in Adult ADHD Phase 1/Phase 2
Completed NCT00586157 - Study of Medication Patch to Treat Children Ages 6-12 With ADHD Phase 4